MIRA INFORM REPORT
|
Report Date : |
23.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
ORIENT PHARMA CO LTD |
|
|
|
|
Registered Office : |
7 Fl, 368 Fu Hsing South Rd, Section 1ta-An Dist Taipei City 106 |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
01.02.2008 |
|
|
|
|
Com. Reg. No.: |
28924399 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Research and Development of Western Pharmaceuticals,
Bio-Pharmaceutical and Other Related Products. Service for Domestic Medical Market (ORIENT EUROPHARMA CO LTD) . |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Status : |
New Company |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
Name & address
ORIENT PHARMA CO
LTD
7FL, 368 FU HSING SOUTH RD
SECTION 1TA-AN DIST TAIPEI CITY 106, TAIWAN
TEL: 886-2-27554881 FAX:
886-2-27024324
EXECUTIVE SUMMARY
INCORPORATION DATE :
FEBRUARY 1, 2008
REGISTRATION NO. :
28924399
LEGAL FORM :
PRIVATE
CHIEF EXECUTIVE :
MR. CHENG-HUNG TSAI (CHAIRMAN)
STAFF STRENGTH :
25
CAPITAL :
US$ 26,272,578
BUSINESS LINE :
R&D, SERVICE
TURNOVER :
N/A (AS OF DEC. 31, 2006)
EQUITIES :
N/A (AS OF DEC. 31, 2006)
PAYMENT :
BELOW AVERAGE
RECOMM. CREDIT RANGE : SMALL
AMOUNT
MARKET CONDITION :
FAIR
FINANCIAL CONDITION :
N/A
OPERATIONAL TREND : FAIRLY STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
TWD 30.37400 = US$1
Adopted abbreviations
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
TWD –Taiwan New Dollars
Registered Legal Address : 1Fl, 256 Shun An St Tounan Chen Yunlin Hsien
630
*Capital Details*
=============
Authorized capital : NTD 800,000,000.00
Paid-up capital : NTD
25,000,000.00
*Office & Facilities*
================
Size : 178 sq
meters (Approx)
Location : Yunlin
Hsien
Property status : Rented
Type of building : Semi-residential building
*Factories, Size & Locations*
======================
The company is focused on R & D of overseas products, and maintains
no manufacturing facilities.
SC is not known to host website of its own at present.
E-mail: hr@mail.oep.com.tw
For the past two years there is no record of litigation.
SC’s shareholder details are not available
at present.
Management: Ms. Su-mei Chen,
Executive
Mr. Cheng-hung Tsai, General Manager
Name Nationality
Job Description Dept. / Division
Ms. Su-mei Chen Taiwanese
Executive Marketing
Mr. Cheng-hung Tsai Taiwanese General Manager -
*Main Products & Services*
======================
Specializing in the following main areas of work:
1. Research and Development of western pharmaceuticals,
bio-pharmaceutical and other related products.
2. Service for domestic medical market (ORIENT EUROPHARMA CO LTD) .
Products: Bio-pharmaceutical research
Biomedical
research
Biotechnology
Biotechnology
R&D
Medical
research
*Payment Terms*
==============
Sales
-------
Local : Cash or credit
Purchases
--------------
Local : Cash or credit
*Competitors*
===========
The following locally based companies supply similar range of products:
- JOIN ENTERPRISE CO LTD
- HEDONIST BIOCHEMICAL TECHNOLOGIES CORP
- SHIRLEY CHEMICAL CORP
- SHILINGMEN CHEMICAL INDUSTRIAL CO LTD
- GENESHUTTLE BIOPHARM INC
*Local Distribution Network*
=======================
100% of the annual turnover is attributed to local sales.
*Export Markets*
==============
There is no record of export since the prime focus of the firm's
activity is concentrated on local sales only.
Note : The company plans to offer its products in the international
market in the future.
*(Subsidiaries , Joint-ventures & Affiliates)
===============================
Company Name : BABECARE CO LTD
Address : 3Fl, 368 Fu Hsing South Rd Section 1 Ta-an Dist Taipei City
Ta-an Dist Taipei City 106 Taiwan
Country : Taiwan
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Cosmetics, Toiletries & Personal Care
Company Name : TAIWAN EXCELSIOR CO LTD
Address : 7Fl, 368 Fu Hsing South Rd Section 1 Ta-an Dist Taipei City
106 Taiwan
Country : Taiwan
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
PAYMENT RATING : 5 OBTAINED SCORES :
20
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the
payment pattern of SC based upon our Payment Database, comments from suppliers
of SC, information from banks (if available), as well as industrial sources.
Additionally, as the company was only incorporated three (6) months ago,
and therefore have not made any financial submissions to local Tax authorities.
*BANK DETAILS*
===============
Bank Name : CHANG HWA COMMERCIAL BANK LTD
Branch : Central Dist,Taichung City
Branch Address : 38 Tzu Yu Rd Section 2 Central Dist Taichung City 400
(Head Office)
SWIFT Code : CCBCTWTP
Bank Name : KING'S TOWN BANK
Branch : Central Dist,Tainan City
Branch Address : 506 Ximen Rd Section 1 Central Dist Tainan City 700
(Head Office)
SWIFT Code : This bank does not have a SWIFT Code
SC was established recently in 2008, and its credit has not been
established yet. The above credit amount appears to be beyond SC’s capacities,
while credit dealings with SC should be confined into small amount at present.
Attached:
trade references
SIC PRODUCT CLASSIFICATION &
ACTIVITY
Activity Code Product/Service Description
Service 7389 Business
Svcs, NEC
Service 8731 Comm
Phys/Biological Research
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Service 9871 Commercial
nonphysical research
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.42.33 |
|
UK Pound |
1 |
Rs.84.32 |
|
Euro |
1 |
Rs.66.75 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)